We're back on [music] Morning Trade Live. Let's focus on retail earnings now. Starting first with Home Depot.The stock is falling in after the big box retailer reported weaker than expected third quarter earnings. The CEO pointing to consumer uncertainty and continued housing market pressure having a negative impact on home improvement demand. So, here's a look at the chart.Here's the price action for the major players in the sector today as well. We've got Lowe's and Costco. Uh we'll have a look at those a ...

Nanterre, November 18th, 2025 Disclosure of transactions in on shares from November 10th to November 14th,2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from November 10th to November 14th,2025: I - Aggregate presentation by day and by market ...

Investors Title Company ( ITIC ) is a large title insurance company in the United States and its financial results are generally linked to the transaction volumes on the real estate market. I was expecting the companyThe Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the leader of the investment group European Small Cap Ideas which offers exclusive ...

Bitcoin treasury company Semler Scientific (Nasdaq: SMLR) CEO Douglas Murphy Chutorian filed to sell up to $30 million shares per two filings with the SEC Tuesday morning. The filing shows the CEO’s intent to sell up to 1.52M shares of SMLR. The proceeds would be equivalent to $30 million quoting the Monday SMLR close price of $20.02 per share. The sale may reflect a desire to monetize a portion of his equity prior to the merger’s completion In September, the bitcoin treasury company announced a merger o ...

AngloGold Ashanti plc ( AU ) shares have delivered a 34% return since my last company's coverage , amidst a sustained gold price rally over the past year. With Q3 2025 now behind us, the company has onceIndividual investor and financial analyst. I mostly cover energy and mining sector companies. When it comes to my investment approach I like businesses with some kind of competitive advantage and excellent future prospects. Particularly, I prioritize good cash flow generation along with a growing income and ...

AngloGold Ashanti plc ( AU ) shares have delivered a 34% return since my last company's coverage , amidst a sustained gold price rally over the past year. With Q3 2025 now behind us, the company has onceIndividual investor and financial analyst. I mostly cover energy and mining sector companies. When it comes to my investment approach I like businesses with some kind of competitive advantage and excellent future prospects. Particularly, I prioritize good cash flow generation along with a growing income and ...

Solana spot ETFs continue to show strength even as SOL and the market slide. Market Overview The average Bitcoin investor is now in in the red after the world’s leading crypto asset briefly fell below $90K for the first time in seven months, but it has since bounced to $91,200. Even though Strategy’s Michael Saylor denied selling BTC and El Salvador splashed $100 million to buy the dip, BTC ended the week 13% down. Is this the end of a bull market, or just a bear trap? It is too early to tell but altc ...

Sandy_Plus / Shutterstock.com Quick Read With a yield of 5.93%, KGC was also upgraded by analysts at Stifel not too long ago. The firm raised its price target on the KGS stock to $48 with a buy rating. Analysts at Loop Capital just reiterated their buy rating on Amazon with a price target of $360. Even with all of the chaos, analysts remain bullish on Nvidia ahead of earnings. Just this morning, Stifel reiterated its buy rating on the tech giant. If you’re thinking about retiring or know someone w ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Question-and-Answer SessionSo Mark, maybe for the audience who might be less familiar with the story, can you maybe start setting the stage by giving us an introduction of -- an overview of RevMed, what's the current pipeline and what have kept you busy for the past year?Mark GoldsmithCEO, President & Chairman Yes. Thanks for having us. Revolution Medicines is a company focused essentially exclusively on the most common genetic cause of cancers that is RAS-driven cancer. We have developed a very rich pipeli ...